Literature DB >> 25554592

Intralesional radiofrequency in venous malformations.

S Garg1, S Kumar2, Y B Singh3.   

Abstract

Venous malformations are usually asymptomatic and managed conservatively. Treatment, in the form of laser, sclerotherapy, or resection, is needed only if lesions present with symptoms or cosmetic deformity. The aim of this study was to find out how effective radiofrequency ablation was in patients with incomplete or unsatisfactory resolution of a venous malformation after an intralesional injection of bleomycin. During the 5 year period 2008-2012, we organised a prospective, clinical study at a tertiary care centre. Patients were selected from the outpatient department of the Lady Hardinge Medical College and associated hospitals, New Delhi, India. Five patients with venous malformations were treated by intralesional injection of bleomycin in a dose of 0.5U/kg body weight, which was repeated every 2 weeks for a total of 8 injections. They then had multiple intralesional radiofrequency ablation every 2 months until a satisfactory outcome was achieved. After the initial 8 doses the reduction in the size of the lesions was minimal (less than 50%). After 2-4 applications of radiofrequency ablation there was appreciable reduction in the size of the lesions (about 80%) with good functional and cosmetic outcomes. Radiofrequency ablation is an effective adjunct for patients with venous malformations of the head and neck that have not responded satisfactorily to intralesional injection of bleomycin. To our knowledge radiofrequency ablation after intralesional injection of bleomycin has not previously been described as a treatment for venous malformations.
Copyright © 2014 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bleomycin; Radiofrequency; Venous malformation

Mesh:

Substances:

Year:  2014        PMID: 25554592     DOI: 10.1016/j.bjoms.2014.10.002

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  5 in total

1.  Angiolymphoid hyperplasia of external ear treated with intralesional radiofrequency ablation.

Authors:  Deepika Yadav; Sanjay Singh; Neetu Bhari; Somesh Gupta
Journal:  BMJ Case Rep       Date:  2018-04-20

2.  Cryoablation of low-flow vascular malformations.

Authors:  Raja S Ramaswamy; Tatulya Tiwari; Michael D Darcy; Seung K Kim; Olaguoke Akinwande; Niloy Dasgupta; Carlos J Guevara
Journal:  Diagn Interv Radiol       Date:  2019-05       Impact factor: 2.630

3.  Percutaneous cryoablation of symptomatic venous malformations as a second-line therapeutic option: a five-year single institution experience.

Authors:  F H Cornelis; F Marin; C Labrèze; V Pinsolle; Y Le Bras; D Midy; N Grenier
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

4.  A 4-year multicentric experience of intravenous cannula-based intralesional radiofrequency ablation as an effective and safe office procedure for common cutaneous nodules.

Authors:  Saurabh Singh; Shanta Passi
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 May-Jun       Impact factor: 2.545

5.  Curative effects of RF combined with DSA-guided ethanol sclerotherapy in venous malformations.

Authors:  Xing Wang; Jian Meng; Jie Zhang; Ruihan Wu; Jianmin Gu; Cuiling Shao; Kun Han
Journal:  Exp Ther Med       Date:  2016-10-13       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.